DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer

DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is a subtype of breast cancer with strong aggressiveness and poor clinical treatment effect, accounting for about 10–20% of breast cancer cases. N(6)-methyldeoxyadenosine (6mA) is the most conservative DNA modification in prokaryotes and eukaryotes. It is widely...

Full description

Bibliographic Details
Main Authors:	Xianneng Sheng, Jinqiu Wang, Yu Guo, Jiabo Zhang, Jin Luo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Oncology
Subjects:	triple negative breast cancer (TNBC) 6mA MDA-MB-231 Olaparib resistance LINP1
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2020.616098/full

Similar Items

A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer
by: Yu-Tien Chang, et al.
Published: (2022-01-01)

STC2 suppresses triple-negative breast cancer migration and invasion by inhibition on EMT and promotion on cell apoptosis
by: Ruiwen Lei, et al.
Published: (2024-08-01)

Immunological Response against Breast Lineage Cells Transfected with Human Papillomavirus (HPV)
by: Daffany Luana Santos, et al.
Published: (2024-04-01)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
by: Damiano Cosimo Rigiracciolo, et al.
Published: (2019-02-01)

Induction of Apoptosis in MDA-MB-231 Cells Treated with the Methanol Extract of Lichen <i>Physconia hokkaidensis</i>
by: Ji-In Noh, et al.
Published: (2021-03-01)

Multifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy
by: Ketki Patil, et al.
Published: (2024-12-01)

Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways
by: Sushma Maharjan, et al.
Published: (2023-04-01)

Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells
by: Basant Emad, et al.
Published: (2023-11-01)

Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer
by: Shradheya R. R. Gupta, et al.
Published: (2023-09-01)

3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 Breast Cancer Cell Line
by: Patricia Bezerra, et al.
Published: (2024-04-01)

A Sesquiterpenoid from Farfarae Flos Induces Apoptosis of MDA-MB-231 Human Breast Cancer Cells through Inhibition of JAK–STAT3 Signaling
by: Hyeri Jang, et al.
Published: (2019-07-01)

MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
by: Kristijan Skok, et al.
Published: (2021-12-01)

Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression
by: Fengliang Wang, et al.
Published: (2021-03-01)

Enhancement of reactive oxygen species production in triple negative breast cancer cells treated with electric pulses and resveratrol
by: Pragatheiswar Giri, et al.
Published: (2023-02-01)

Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel
by: Sebastian Simu, et al.
Published: (2021-05-01)

Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC)
by: Damiano Cosimo Rigiracciolo, et al.
Published: (2022-06-01)

PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress
by: Vanessa Castelli, et al.
Published: (2021-01-01)

Investigating the Anticancer Activity and Characterization of Bioactive Constituents of <i>Moricandia sinaica (Boiss.) Boiss</i> through In Vitro and In Silico Approaches in Triple-Negative Breast Cancer Cell Line
by: Muhammad Farooq Khan, et al.
Published: (2021-01-01)

A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
by: Raiane Aparecida dos Santos Machado, et al.
Published: (2024-12-01)

Ethanolic Extract of <i>Averrhoa carambola</i> Leaf Has an Anticancer Activity on Triple-Negative Breast Cancer Cells: An In Vitro Study
by: Oscar F. Beas-Guzmán, et al.
Published: (2024-12-01)

Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
by: Katharina Gohr, et al.
Published: (2017-11-01)

SYNTHESIS AND EVALUATION OF BIOACTIVE PEPTIDES FROM LAMININ-111 IN TRIPLE-NEGATIVE BREAST CANCER CELLS
by: Fernanda Ferreira Mendonça, et al.
Published: (2024-04-01)

Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics Methodology
by: Kailin Yang, et al.
Published: (2020-06-01)

HOXB7 Overexpression Leads Triple-Negative Breast Cancer Cells to a Less Aggressive Phenotype
by: Simone Aparecida de Bessa Garcia, et al.
Published: (2021-05-01)

Meme kanseri hücre hatlarında propranolol ve paklitakselin anjiyogenez üzerine etkisi
by: Fatma Şimşek, et al.
Published: (2019-03-01)

A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer
by: Sambi M, et al.
Published: (2020-05-01)

Anti-PTK7 Monoclonal Antibodies Suppresses Oncogenic Phenotypes in Cellular and Xenograft Models of Triple-Negative Breast Cancer
by: Min Ho Kim, et al.
Published: (2025-01-01)

Galangin promotes apoptosis by upregulating the pro-apoptotic gene BAX in triple-negative breast cancer
by: Shruti Sinnarkar, et al.
Published: (2024-12-01)

Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics
by: Tatiana J. Carneiro, et al.
Published: (2023-12-01)

Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets
by: Murat Kaya, et al.
Published: (2024-04-01)

In Vitro Antimicrobial Activity of Isopimarane-Type Diterpenoids
by: Vera M. S. Isca, et al.
Published: (2020-09-01)

Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
by: Kurt Buchegger, et al.

Synthesis of the C<sub>3</sub> and C<sub>1</sub> Constitutional Isomers of Trifluorosubphthalocyanine and Their Fluorescence within MDA-MB-231 Breast Tumor Cells
by: Rosemarie L. Calandrino, et al.
Published: (2019-10-01)

Phytochemical profile and antiproliferative effect of Ficus crocata extracts on triple-negative breast cancer cells
by: Carlos A. Sánchez-Valdeolívar, et al.
Published: (2020-06-01)

Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line
by: Neelam Mishra, et al.
Published: (2021-11-01)

Metabolomics insights into doxorubicin and 5-fluorouracil combination therapy in triple-negative breast cancer: a xenograft mouse model study
by: Mai M. Hassanein, et al.
Published: (2025-01-01)

Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer
by: Marshall D. Behrens, et al.
Published: (2022-12-01)

Detecting heterogeneity in and between breast cancer cell lines
by: Yang Shen, et al.
Published: (2020-02-01)

Polysaccharide from Sepia esculenta ink and cisplatin inhibit synergistically proliferation and metastasis of triple-negative breast cancer MDA-MB-231 cells
by: Hua-Zhong Liu, et al.
Published: (2016-12-01)

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells
by: Madalina Andreea Badea, et al.
Published: (2018-11-01)